FDA clears Sekisui Diagnostics’ rapid combo test for COVID-19 and flu A&B, offering CLIA-waived, 510(k)-cleared pathogen ...
15h
SEKISUI Diagnostics Announces 510(k) Clearance and Launch of the OSOM® COVID-19/Flu A&B Combo Test
SEKISUI Diagnostics, a global medical diagnostics manufacturer, has announced the launch of a 510(k) cleared rapid test to detect COVID-19 and Flu A&B in professional healthcare settings.
Scientists and public health experts built the COVID-19 pandemic response on years of experience navigating infectious disease outbreaks. Although lateral flow immunoassays have been central to ...
Medicare Part B covers COVID-19 tests when conducted in laboratories. Part A may cover lab tests if needed in hospital or skilled nursing facility settings. Since 2023, Medicare has no longer covered ...
Holly has a degree in Medical Biochemistry from the University of Leicester. Her scientific interests include genomics, personalized medicine, and bioethics.View full profile Holly has a degree in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results